BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20718729)

  • 1. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
    Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
    Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
    Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
    Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
    Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
    Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation.
    Kagaya H; Miura M; Saito M; Habuchi T; Satoh S
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):631-6. PubMed ID: 20136638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.
    Wang J; Yang JW; Zeevi A; Webber SA; Girnita DM; Selby R; Fu J; Shah T; Pravica V; Hutchinson IV; Burckart GJ
    Clin Pharmacol Ther; 2008 May; 83(5):711-7. PubMed ID: 17851563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine monophosphate dehydrogenase expression and activity are significantly lower in kidney transplant recipients with diabetes mellitus.
    Dostalek M; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2013 Jun; 35(3):374-83. PubMed ID: 23666569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpopulation variation frequency of human inosine 5'-monophosphate dehydrogenase type II (IMPDH2) genetic polymorphisms.
    Mohamed MF; Frye RF; Langaee TY
    Genet Test; 2008 Dec; 12(4):513-6. PubMed ID: 18976158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
    Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
    Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells.
    Bremer S; Rootwelt H; Bergan S
    Clin Chem; 2007 Jun; 53(6):1023-9. PubMed ID: 17463174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malnutrition Risk in Kidney Recipients Treated With Mycophenolate Mofetil Is Associated With IMPDH1 rs2278294 Polymorphism.
    Pazik J; Lewandowski Z; Nowacka Cieciura E; Ołdak M; Podgórska M; Sadowska A; Dęborska Materkowska D; Durlik M
    Transplant Proc; 2018; 50(6):1794-1797. PubMed ID: 30056902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
    Bremer S; Vethe NT; Rootwelt H; Jørgensen PF; Stenstrøm J; Holdaas H; Midtvedt K; Bergan S
    J Transl Med; 2009 Jul; 7():64. PubMed ID: 19635156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid.
    Cheng L; Yao P; Weng B; Yang M; Wang Q
    Eur J Clin Pharmacol; 2022 Aug; 78(8):1227-1238. PubMed ID: 35524809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of IMPDH1 is regulated in response to mycophenolate concentration.
    Bremer S; Vethe NT; Rootwelt H; Bergan S
    Int Immunopharmacol; 2009 Feb; 9(2):173-80. PubMed ID: 19010451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of inosine monophosphate dehydrogenase activity and expression during the early period of mycophenolate mofetil therapy in de novo renal transplant patients.
    Molinaro M; Chiarelli LR; Biancone L; Castagneto M; Boschiero L; Pisani F; Sabbatini M; Sandrini S; Arbustini E; Tinelli C; Regazzi M; Schena FP; Segoloni GP
    Drug Metab Pharmacokinet; 2013; 28(2):109-17. PubMed ID: 22892445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
    Garat A; Cauffiez C; Hamdan-Khalil R; Glowacki F; Devos A; Leclerc J; Lionet A; Allorge D; Lo-Guidice JM; Broly F
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):841-7. PubMed ID: 19810816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.
    Dang W; Yin Y; Wang Y; Wang W; Su J; Sprengers D; van der Laan LJW; Felczak K; Pankiewicz KW; Chang KO; Koopmans MPG; Metselaar HJ; Peppelenbosch MP; Pan Q
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
    Fellenberg J; Kunz P; Sähr H; Depeweg D
    PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
    Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
    PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism.
    Pazik J; Ołdak M; Podgórska M; Lewandowski Z; Sitarek E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
    Transplant Proc; 2011 Oct; 43(8):2943-5. PubMed ID: 21996196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.
    Ohmann EL; Burckart GJ; Brooks MM; Chen Y; Pravica V; Girnita DM; Zeevi A; Webber SA
    J Heart Lung Transplant; 2010 May; 29(5):509-16. PubMed ID: 20061166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.